Status:
COMPLETED
Ultrasonographic Evaluation of Diabetic Neuropathy
Lead Sponsor:
Cukurova University
Conditions:
Diabetic Peripheral Neuropathy
Eligibility:
All Genders
18-65 years
Brief Summary
The current study aimed to evaluate the cross-sectional area (CSA) of peripheral nerves in people with diabetic peripheral neuropathy using ultrasonography and correlate the CSA with clinical and demo...
Detailed Description
Patients with diabetic peripheral neuropathy (n=53) and a matched healthy control group (n=53) underwent blinded ultrasonography imaging of the sciatic, tibial and median nerves. Matching was performe...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- type 2 diabetes mellitus
- Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) scores ≥ 12
- probable diabetic peripheral neuropathy according to the diabetic peripheral neuropathy criteria.
- Exclusion Criteria
- type 1 diabetes mellitus
- hypothyroidism
- LANSS pain scale scores \< 12
- body mass index (BMI) \> 35
- current pregnancy
- histories of hereditary neuropathy, inflammatory neuropathy, nerve trauma, or other known causes of polyneuropathy; and the use of anti-neuropathic drugs.
Exclusion
Key Trial Info
Start Date :
April 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT02308059
Start Date
April 1 2012
End Date
December 1 2014
Last Update
December 4 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.